Literature DB >> 16432020

Non-structural proteins of dengue 2 virus offer limited protection to interferon-deficient mice after dengue 2 virus challenge.

Amanda E Calvert1, Claire Y-H Huang, Richard M Kinney, John T Roehrig.   

Abstract

Chimeric (D2/WN) viruses containing the pre-membrane (prM) and envelope (E) proteins of West Nile virus (WN virus) and the capsid (C) and non-structural proteins of dengue 2 (DEN2) virus were used to evaluate the protective immunity elicited by either the flaviviral E protein or non-structural proteins. AG129 interferon-deficient mice, previously shown to be protected against lethal DEN1 or DEN2 viral infection after vaccination with a wild-type or candidate vaccine strain of DEN1 or DEN2 virus, respectively, were immunized with chimeric D2/WN virus and then challenged with DEN2 virus. D2/WN chimeric viruses were non-pathogenic in AG129 mice. These viruses elicited little anti-DEN E antibody, high levels of anti-DEN NS1 antibody and no or very low levels of DEN2 virus-neutralizing antibodies. Only 15% of D2/WN-immunized mice survived challenge with DEN2 virus. However, their mean survival time increased by 11-14 days over non-immunized controls. These results suggest that, whilst the non-structural proteins were able to enhance mean survival times of AG129 mice, this protection was not as effective as protection mediated by the E protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16432020     DOI: 10.1099/vir.0.81256-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

1.  Antibody recognition of the dengue virus proteome and implications for development of vaccines.

Authors:  Stefan Fernandez; Emily D Cisney; Alexander P Tikhonov; Barry Schweitzer; Robert J Putnak; Monika Simmons; Robert G Ulrich
Journal:  Clin Vaccine Immunol       Date:  2011-01-26

2.  A Monoclonal Antibody Specific for Japanese Encephalitis Virus with High Neutralizing Capability for Inclusion as a Positive Control in Diagnostic Neutralization Tests.

Authors:  Amanda E Calvert; Susan L Bennett; Kandice L Dixon; Carol D Blair; John T Roehrig
Journal:  Am J Trop Med Hyg       Date:  2019-07       Impact factor: 2.345

Review 3.  Theoretical aspects of immunity.

Authors:  Michael W Deem; Pooya Hejazi
Journal:  Annu Rev Chem Biomol Eng       Date:  2010       Impact factor: 11.059

4.  Development of a small animal peripheral challenge model of Japanese encephalitis virus using interferon deficient AG129 mice and the SA14-14-2 vaccine virus strain.

Authors:  Amanda E Calvert; Kandice L Dixon; Mark J Delorey; Carol D Blair; John T Roehrig
Journal:  Vaccine       Date:  2013-11-17       Impact factor: 3.641

5.  Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections.

Authors:  Tomer Hertz; P Robert Beatty; Zachary MacMillen; Sarah S Killingbeck; Chunling Wang; Eva Harris
Journal:  J Immunol       Date:  2017-04-05       Impact factor: 5.422

6.  Construction and characterization of a single-cycle chimeric flavivirus vaccine candidate that protects mice against lethal challenge with dengue virus type 2.

Authors:  Ryosuke Suzuki; Evandro R Winkelmann; Peter W Mason
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

Review 7.  Mouse models of dengue virus infection and disease.

Authors:  Lauren E Yauch; Sujan Shresta
Journal:  Antiviral Res       Date:  2008-07-09       Impact factor: 5.970

8.  Generation of human single-chain variable fragment antibodies specific to dengue virus non-structural protein 1 that interfere with the virus infectious cycle.

Authors:  Ornnuthchar Poungpair; Kunan Bangphoomi; Prapaipit Chaowalit; Nunghathai Sawasdee; Nichapatr Saokaew; Kiattawee Choowongkomon; Wanpen Chaicumpa; Pa-thai Yenchitsomanus
Journal:  MAbs       Date:  2014-01-15       Impact factor: 5.857

9.  Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model.

Authors:  Jennifer L Kyle; Scott J Balsitis; Luhua Zhang; P Robert Beatty; Eva Harris
Journal:  Virology       Date:  2008-09-06       Impact factor: 3.616

Review 10.  Animal models of dengue virus infection.

Authors:  Simona Zompi; Eva Harris
Journal:  Viruses       Date:  2012-01-09       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.